ADVANCED HEPATOCELLULAR CARCINOMA

Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 3 Not yet finished but already full! 5 Completed 4 Terminated 1

Early-Stop for liver cancer drug combo trial

Disease control Terminated

This early-stage study tested a new two-drug combination (TQB2223 and penpulimab) for people with advanced liver cancer that had spread. The main goal was to check the safety and initial signs of effectiveness of this treatment. The study was terminated after enrolling 22 partici…

Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA

Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ADVANCED HEPATOCELLULAR CARCINOMA

Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear

Early-Stop for liver cancer drug combo trial